Schedule 13G ownership disclosure

TENAX THERAPEUTICS, INC.

Security class unavailable · CUSIP: 88032L100

Event date: 2018-12-31

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
21,519
Percent of class
9.9900%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000930413-19-000506
Form type
SC 13G/A
Filer
Iroquois Capital Management, LLC
CIK
CIK 1481867
Filed
Feb 14, 2019
Reporting period
Dec 31, 2018
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub